Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemiaRenato Bassan, Alessandro Rambaldi, E. Di Bona et al.|Blood Cancer Journal|2014Cited by 63
Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07Renato Bassan, Alessandro Rambaldi, Tamara Intermesoli et al.|Blood|2010Cited by 2
Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).Renato Bassan, Alessandro Rambaldi, Orietta Spinelli et al.|Blood|2012Cited by 1
In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.Renato Bassan, Alessandro Rambaldi, Ernesta Audisio et al.|Blood|2012Cited by 1